Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 1
1983 2
1985 1
1987 5
1988 4
1989 3
1990 4
1991 3
1992 14
1993 12
1994 23
1995 19
1996 17
1997 16
1998 30
1999 17
2000 29
2001 25
2002 20
2003 38
2004 49
2005 62
2006 80
2007 91
2008 109
2009 125
2010 158
2011 168
2012 213
2013 302
2014 306
2015 331
2016 319
2017 395
2018 466
2019 558
2020 626
2021 705
2022 77
Text availability
Article attribute
Article type
Publication date

Search Results

4,829 results
Results by year
Filters applied: . Clear all
Page 1
Diverse alterations associated with resistance to KRAS(G12C) inhibition.
Zhao Y, Murciano-Goroff YR, Xue JY, Ang A, Lucas J, Mai TT, Da Cruz Paula AF, Saiki AY, Mohn D, Achanta P, Sisk AE, Arora KS, Roy RS, Kim D, Li C, Lim LP, Li M, Bahr A, Loomis BR, de Stanchina E, Reis-Filho JS, Weigelt B, Berger M, Riely G, Arbour KC, Lipford JR, Li BT, Lito P. Zhao Y, et al. Among authors: xue jy. Nature. 2021 Nov;599(7886):679-683. doi: 10.1038/s41586-021-04065-2. Epub 2021 Nov 10. Nature. 2021. PMID: 34759319
Editorial.
Grimm J, Jackson A, Kavanagh BD, Marks LB, Yorke E, Xue J. Grimm J, et al. Among authors: xue j. Med Phys. 2021 Jun;48(6):2699-2700. doi: 10.1002/mp.14913. Med Phys. 2021. PMID: 34235767 No abstract available.
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12).
Zhou C, Wu L, Fan Y, Wang Z, Liu L, Chen G, Zhang L, Huang D, Cang S, Yang Z, Zhou J, Zhou C, Li B, Li J, Fan M, Cui J, Li Y, Zhao H, Fang J, Xue J, Hu C, Sun P, Du Y, Zhou H, Wang S, Zhang W. Zhou C, et al. Among authors: xue j. J Thorac Oncol. 2021 Sep;16(9):1501-1511. doi: 10.1016/j.jtho.2021.04.011. Epub 2021 May 25. J Thorac Oncol. 2021. PMID: 34048947 Clinical Trial.
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients.
Li Y, Ma ML, Lei Q, Wang F, Hong W, Lai DY, Hou H, Xu ZW, Zhang B, Chen H, Yu C, Xue JB, Zheng YX, Wang XN, Jiang HW, Zhang HN, Qi H, Guo SJ, Zhang Y, Lin X, Yao Z, Wu J, Sheng H, Zhang Y, Wei H, Sun Z, Fan X, Tao SC. Li Y, et al. Among authors: xue jb. Cell Rep. 2021 Mar 30;34(13):108915. doi: 10.1016/j.celrep.2021.108915. Epub 2021 Mar 12. Cell Rep. 2021. PMID: 33761319 Free PMC article.
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response.
Wang Y, Liang Y, Xu H, Zhang X, Mao T, Cui J, Yao J, Wang Y, Jiao F, Xiao X, Hu J, Xia Q, Zhang X, Wang X, Sun Y, Fu D, Shen L, Xu X, Xue J, Wang L. Wang Y, et al. Among authors: xue j. Cell Discov. 2021 May 25;7(1):36. doi: 10.1038/s41421-021-00271-4. Cell Discov. 2021. PMID: 34035226 Free PMC article.
Mechanisms of Connexin Regulating Peptides.
King DR, Sedovy MW, Leng X, Xue J, Lamouille S, Koval M, Isakson BE, Johnstone SR. King DR, et al. Among authors: xue j. Int J Mol Sci. 2021 Sep 22;22(19):10186. doi: 10.3390/ijms221910186. Int J Mol Sci. 2021. PMID: 34638526 Free PMC article. Review.
4,829 results